Allergan plc Company Profile (NYSE:ACT)

About Allergan plc

Allergan plc logoActavis, Inc. formerly Watson Pharmaceuticals, Inc., is a integrated global specialty pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand, biosimilar and over-the-counter (OTC) pharmaceutical products. The Company also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. The Company operates in three segments: Actavis Pharma, Actavis Specialty Brands and Anda Distribution. On January 23, 2013, the Company completed the acquisition of Uteron Pharma SA. On October 29, 2012, the Company sold its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group, L.L.C. On January 24, 2012, the Company completed the acquisition of Ascent Pharmahealth Ltd.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: ACT
  • CUSIP: 00507K10
Key Metrics:
  • Previous Close: $299.00
  • 50 Day Moving Average: $297
  • 200 Day Moving Average: $285
  • 52-Week Range: $202.00 - $318.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 14.24
  • P/E Growth: 0
  • Market Cap: $N/A
Additional Links:
Companies Related to Allergan plc:

Analyst Ratings

Consensus Ratings for Allergan plc (NYSE:ACT) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $215.00 (28.09% downside)

Analysts' Ratings History for Allergan plc (NYSE:ACT)
Show:
DateFirmActionRatingPrice TargetDetails
3/28/2016Leerink SwannBoost Price TargetOutperform$180.00 -> $215.00View Rating Details
11/2/2015Susquehanna Bancshares IncBoost Price TargetPositive$290.00 -> $325.00View Rating Details
6/4/2015Bank of America CorpSet Price TargetBuy$350.00View Rating Details
6/3/2015Raymond James Financial, Inc.Initiated CoverageOutperform$344.00View Rating Details
5/29/2015Deutsche Bank AGBoost Price TargetBuy$336.00 -> $343.00View Rating Details
5/29/2015Canaccord GenuityReiterated RatingBuy$352.00View Rating Details
5/28/2015Citigroup Inc.Initiated CoverageFocus List -> Focus List$360.00View Rating Details
5/11/2015GuggenheimSet Price TargetBuy$345.00 -> $355.00View Rating Details
5/8/2015Barclays PLCSet Price TargetHold$300.00View Rating Details
5/8/2015MizuhoInitiated CoverageBuy$358.00View Rating Details
4/8/2015Royal Bank Of CanadaReiterated RatingPositive$361.00View Rating Details
3/24/2015Sterne Agee CRTReiterated RatingBuy$315.00 -> $340.00View Rating Details
3/18/2015BMO Capital MarketsBoost Price TargetBuy$286.00 -> $373.00View Rating Details
3/17/2015Goldman Sachs Group, Inc. (The)Initiated CoverageBuy$365.00View Rating Details
3/11/2015J P Morgan Chase & CoInitiated CoverageOverweight$310.00 -> $375.00View Rating Details
3/6/2015Edward JonesInitiated CoverageBuyView Rating Details
2/25/2015Sanford C. BernsteinBoost Price TargetOutperform$315.00 -> $350.00View Rating Details
2/20/2015ArgusBoost Price TargetBuy$310.00 -> $340.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Allergan plc (NYSE:ACT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2015        
5/11/2015Q115$3.84$4.30$4.04 billion$4.23 billionViewListenView Earnings Details
2/18/2015Q414$3.67$3.91$3.84 billion$4.01 billionViewN/AView Earnings Details
11/5/2014Q314$3.10$3.19$3.63 billion$3.68 billionViewN/AView Earnings Details
8/5/2014Q214$3.36$3.42$2.55 billion$2.67 billionViewN/AView Earnings Details
4/30/2014Q114$3.23$3.49$2.59 billion$2.66 billionViewListenView Earnings Details
2/20/2014Q413$3.05$3.17$2.68 billion$2.78 billionViewListenView Earnings Details
10/29/2013Q313$2.09$2.09$2.04 billion$2.01 billionViewListenView Earnings Details
7/25/2013Q2 2013$2.00$2.01$1.99 billion$1.99 billionViewListenView Earnings Details
5/2/2013Q1 2013$1.86$1.99$1.97 billion$1.90 billionViewListenView Earnings Details
2/19/2013Q4 2012$1.53$1.59$1.74 million$1.75 billionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Allergan plc (NYSE:ACT)
Current Year EPS Consensus Estimate: $18 EPS
Next Year EPS Consensus Estimate: $21 EPS

Dividends

Dividend History for Allergan plc (NYSE:ACT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Allergan plc (NYSE:ACT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2015Nesli BasgozDirectorSell2,200$297.89$655,358.00View SEC Filing  
11/26/2014William MeuryInsiderSell4,550$269.14$1,224,587.00View SEC Filing  
9/8/2014Albert Paonessa IIIInsiderSell6,642$230.49$1,530,914.58View SEC Filing  
9/16/2013Albert HummelDirectorSell6,200$137.81$854,422.00View SEC Filing  
9/4/2013George Fred WilkinsonInsiderSell16,749$138.00$2,311,362.00View SEC Filing  
9/4/2013Jack MichelsonDirectorSell6,064$139.54$846,170.56View SEC Filing  
8/29/2013David BuchenInsiderSell10,000$135.56$1,355,600.00View SEC Filing  
8/26/2013Albert HummelDirectorSell40,000$134.44$5,377,600.00View SEC Filing  
8/20/2013Paul BisaroCEOSell50,000$135.30$6,765,000.00View SEC Filing  
8/15/2013Albert Paonessa IIIInsiderSell5,476$135.89$744,133.64View SEC Filing  
8/14/2013R Todd JoyceCFOSell15,000$137.98$2,069,700.00View SEC Filing  
8/13/2013Albert HummelDirectorSell10,000$133.85$1,338,500.00View SEC Filing  
8/12/2013Cathy KlemaDirectorSell1,667$133.03$221,761.01View SEC Filing  
8/12/2013David BuchenInsiderSell17,000$133.03$2,261,510.00View SEC Filing  
8/9/2013Ronald TaylorDirectorSell5,000$135.14$675,700.00View SEC Filing  
8/5/2013Charles EbertVPSell8,244$136.25$1,123,245.00View SEC Filing  
8/5/2013Michel FeldmanDirectorSell10,000$136.94$1,369,400.00View SEC Filing  
8/2/2013Robert StewartInsiderSell14,564$136.02$1,980,995.28View SEC Filing  
3/14/2013Charles M MayrInsiderSell1,000$91.77$91,770.00View SEC Filing  
3/12/2013Michael J FedidaDirectorSell8,000$89.00$712,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Allergan plc (NYSE:ACT)
DateHeadline
investopedia.com logoRoche Sues Amgen Over Avastin Biosimilar (AMGN) (NYSE:ACT)
www.investopedia.com - February 20 at 3:18 PM
News IconDry Eye Syndrome Treatment Market Trends and Segments 2016-2026 (NYSE:ACT)
reports.pr-inside.com - February 16 at 8:21 PM
openpr.com logoGrowing demand for Allergy Treatment Market 2024 (NYSE:ACT)
www.openpr.com - February 16 at 8:21 PM
News IconTwo sheep lose their lambs after dog attack (NYSE:ACT)
eleganthomesinla.com - February 16 at 8:21 PM
News IconTwo sheep lose their lambs after dog attack (NYSE:ACT)
eleganthomesinla.com - February 16 at 8:21 PM
4-traders.com logoAllergan Launches See AmericaSM, a Bold Initiative Furthering the Fight Against Preventable Blindness (NYSE:ACT)
www.4-traders.com - February 16 at 8:21 PM
4-traders.com logoAllergan Launches See AmericaSM, a Bold Initiative Furthering the Fight Against Preventable Blindness (NYSE:ACT)
www.4-traders.com - February 16 at 8:21 PM
News IconAllergan Stock Losses Spawn ERISA Class Action - Bloomberg BNA (NYSE:ACT)
www.bna.com - February 16 at 3:21 PM
finance.yahoo.com logoDavid Tepper Invests Heavily in Pharma in 4th Quarter (NYSE:ACT)
finance.yahoo.com - February 16 at 3:21 PM
investopedia.com logoTepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016 (PFE, MYL) - Investopedia (NYSE:ACT)
www.investopedia.com - February 16 at 6:31 AM
News IconAllergan to Purchase Zeltiq, Bolstering Aesthetics and Regenerative Units - Pharmaceutical Processing (NYSE:ACT)
www.pharmpro.com - February 16 at 6:31 AM
thestreet.com logo5 Ways Allergan Can Keep Up Momentum (NYSE:ACT)
www.thestreet.com - February 16 at 6:31 AM
marketwatch.com logoAppaloosa Management snaps up Allergan shares in 4th quarter (NYSE:ACT)
www.marketwatch.com - February 14 at 8:35 PM
finance.yahoo.com logoDavid Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks (NYSE:ACT)
finance.yahoo.com - February 14 at 8:35 PM
News IconUS drug pricing pressures build toward the perfect storm - BioWorld Online (NYSE:ACT)
www.bioworld.com - February 14 at 3:32 PM
News IconAllergan PLC. (AGN) stock falls, “Buy” rating reaffirmed by Credit Suisse Group Analysts - The Ledger Gazette (NYSE:ACT)
ledgergazette.com - February 14 at 3:32 PM
thestreet.com logoValeant, Pershing Square to Split Legal Fees on Allergan Lawsuit (NYSE:ACT)
www.thestreet.com - February 14 at 3:32 PM
investors.com logoHologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil (NYSE:ACT)
www.investors.com - February 14 at 3:32 PM
finance.yahoo.com logoAllergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion (NYSE:ACT)
in.finance.yahoo.com - February 13 at 8:24 PM
finance.yahoo.com logoAllergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13% (NYSE:ACT)
finance.yahoo.com - February 13 at 8:24 PM
cnbc.com logoTeva Pharma quarterly profit and revenue beat expectations (NYSE:ACT)
www.cnbc.com - February 13 at 9:31 AM
News IconTeva Pharmaceuticals beats on the top and bottom lines (NYSE:ACT)
www.businessinsider.com - February 13 at 8:29 AM
finance.yahoo.com logoPharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi (NYSE:ACT)
finance.yahoo.com - February 10 at 3:22 PM
prnewswire.com logoAASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - February 9 at 8:21 PM
prnewswire.com logoAllergan to Present at The Leerink Partners 6th Annual Global Healthcare Conference - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - February 9 at 8:21 PM
finance.yahoo.com logoCompany News for February 09, 2017 (NYSE:ACT)
finance.yahoo.com - February 9 at 3:18 PM
thestreet.com logoCramer: Here's the Reason for Allergan's Remarkable Run (NYSE:ACT)
www.thestreet.com - February 9 at 3:18 PM
News IconAllergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 - Satellite PR News (press release) (NYSE:ACT)
www.satprnews.com - February 8 at 8:24 PM
cnbc.com logoCramer Remix: Why you would be an idiot to sell Disney (NYSE:ACT)
www.cnbc.com - February 8 at 8:24 PM
thestreet.com logoAllergan: Cramer's Top Takeaways (NYSE:ACT)
www.thestreet.com - February 8 at 8:24 PM
prnewswire.com logoAllergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - February 8 at 3:23 PM
sg.finance.yahoo.com logoAllergan reports 4Q loss (NYSE:ACT)
sg.finance.yahoo.com - February 8 at 3:23 PM
finance.yahoo.com logoAllergan beats profit estimates, forecasts upbeat 2017 (NYSE:ACT)
finance.yahoo.com - February 8 at 3:23 PM
finance.yahoo.com logoAllergan (AGN) Beats Q4 Earnings & Sales; Shares Up (NYSE:ACT)
finance.yahoo.com - February 8 at 3:23 PM
finance.yahoo.com logoAllergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat (NYSE:ACT)
finance.yahoo.com - February 8 at 3:23 PM
thestreet.com logoAllergan Tops Revenue Forecast -- Plus Jim Cramer's Comments (NYSE:ACT)
www.thestreet.com - February 8 at 3:23 PM
wsj.com logo[$$] Allergan Results Boosted by New, Established Drugs (NYSE:ACT)
www.wsj.com - February 8 at 3:23 PM
investors.com logoAllergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance (NYSE:ACT)
www.investors.com - February 8 at 3:23 PM
finance.yahoo.com logoAllergan says U.S. tax reform unlikely in 2017, sees strong year (NYSE:ACT)
finance.yahoo.com - February 8 at 3:23 PM
thestreet.com logoAllergan's Fourth-Quarter Comments Should Comfort Investors (NYSE:ACT)
www.thestreet.com - February 8 at 3:23 PM
insidermonkey.com logoAllergan PLC (AGN) Launches Campaign To Fight Preventable Blindness In America (NYSE:ACT)
www.insidermonkey.com - February 8 at 3:23 PM
prnewswire.com logoAllergan Launches See America(SM), a Bold Initiative Furthering the ... - PR Newswire (press release) (NYSE:ACT)
www.prnewswire.com - February 7 at 3:24 PM
streetinsider.com logoForm SC 13G/A Allergan plc Filed by: PRICE T ROWE ASSOCIATES INC /MD/ - StreetInsider.com (NYSE:ACT)
www.streetinsider.com - February 7 at 3:24 PM
News IconAllergan PLC. (AGN) stock trades up, “Buy” rating reaffirmed by Mizuho Analysts - The Ledger Gazette (NYSE:ACT)
ledgergazette.com - February 7 at 3:24 PM
finance.yahoo.com logoDrug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More (NYSE:ACT)
finance.yahoo.com - February 7 at 3:24 PM
ft.com logo[$$] Biotech chiefs from 160 groups attack Trump travel ban (NYSE:ACT)
www.ft.com - February 7 at 3:24 PM
thestreet.com logoAllergan Followers Optimistic Ahead of Wednesday's Fourth-Quarter Report (NYSE:ACT)
www.thestreet.com - February 7 at 3:24 PM
bizjournals.com logoAllergan pledges to battle blindness with 'See America' initiative (NYSE:ACT)
www.bizjournals.com - February 7 at 1:25 AM
finance.yahoo.com logoWhy Earnings Season Could Be Great for Allergan (AGN) (NYSE:ACT)
finance.yahoo.com - February 6 at 3:22 PM
marketwatch.com logoDriven by Botox, Allergan’s 2017 expected to be a standout (NYSE:ACT)
www.marketwatch.com - February 6 at 3:22 PM

Social

What is Allergan plc's stock symbol?

Allergan plc trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACT."

Where is Allergan plc's stock going? Where will Allergan plc's stock price be in 2017?

1 brokers have issued 1-year target prices for Allergan plc's stock. Their forecasts range from $215.00 to $215.00. On average, they anticipate Allergan plc's share price to reach $215.00 in the next year.

When will Allergan plc announce their earnings?

Allergan plc is scheduled to release their next quarterly earnings announcement on Monday, August, 3rd 2015.

How do I buy Allergan plc stock?

Shares of Allergan plc can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Allergan plc stock cost?

One share of Allergan plc stock can currently be purchased for approximately $299.00.

Allergan plc (NYSE:ACT) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Allergan plc (NYSE:ACT)

Earnings History Chart

Earnings by Quarter for Allergan plc (NYSE:ACT)

Dividend History Chart

Dividend Payments by Quarter for Allergan plc (NYSE:ACT)

Last Updated on 2/20/2017 by MarketBeat.com Staff